Deutsche Bank plans trigger autocallable securities tied to Pfizer

By Marisa Wong

Madison, Wis., Dec. 4 – Deutsche Bank AG, London Branch plans to price 0% trigger autocallable optimization securities due Dec. 11, 2019 linked to the common stock of Pfizer Inc., according to an FWP filing with the Securities and Exchange Commission.

Beginning one year after issuance, the notes will be called at par plus a call return of 7% per year if Pfizer shares close at or above the initial share price on any quarterly observation date.

If the notes are not called and Pfizer shares finish at or above the trigger price, 64% to 70% of the initial share price, the payout at maturity will be par. Otherwise, investors will be exposed to the share price decline from the initial price.

UBS Financial Services Inc. and Deutsche Bank Securities Inc. are the underwriters.

The notes will price on Dec. 5 and settle on Dec. 10.

The Cusip number is 25190A658.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.